文献速递运动医学关节外科

髋关节镜翻修术中应用关节囊间隔物治疗关节囊盂唇粘连的疗效

Outcomes for Treatment of Capsulolabral Adhesions With a Capsular Spacer During Revision Hip Arthroscopy.
PubMed 文献 · Am J Sports Med · 2023-01-20

本研究为病例系列(证据等级4),评估95例(99髋)因关节囊粘连行髋关节镜翻修术并放置关节囊间隔物的患者中,53例(56髋)完成至少2年随访者的患者报告结局与生存率。2年无关节置换及无翻修生存率为91%,5例(6髋;11%)平均2.4±1.4年后再行翻修手术,4例(7%)转为全髋关节置换;未再手术的46髋中,除SF-12心理成分总结外,各项结局评分显著改善。作者认为关节囊间隔物应被考虑用于翻修髋关节镜手术中,当盂唇体积足够但粘连仍是顾虑时。

要点

  • 2年无关节置换及无翻修生存率为91%,5例(6髋;11%)平均2.4±1.4年后再行翻修。
  • 4例(7%)转为全髋关节置换。
  • 未再手术的46髋中,除SF-12心理成分总结外,结局评分显著改善,mHHS、HOS-ADL、HOS-SSS达到最小临床重要差异的比率分别为70%、70%、65%。

核心结论

  • 关节囊间隔物作为系统方法的一部分,包括粘连松解和术后早期持续物理治疗(含环转运动),在至少2年随访时改善了患者报告结局,并取得较高的无关节置换及无翻修生存率(91%)。
  • 作者认为,当盂唇体积足够但粘连仍是顾虑时,翻修髋关节镜手术中应考虑使用关节囊间隔物。

研究设计与样本

  • 病例系列研究,证据等级4。
  • 2013年1月至2018年6月间,共95例患者(99髋)年龄≥18岁,因关节囊粘连行髋关节镜翻修术并放置关节囊间隔物。
  • 53例患者(56髋)符合纳入标准并完成至少2年随访,构成本研究队列。
  • 排除标准包括 confounding 代谢性骨病(如 Legg-Calve-Perthes 病、Marfan 综合征)、盂唇缺损或晚期骨关节炎(Tönnis 2级或3级)。

主要发现

  • 队列平均年龄32±11岁,女性髋32例(57%),既往髋关节镜手术次数中位数为1次(范围1-5次)。
  • 2年无关节置换及无翻修生存率为91%。
  • 5例患者(6髋;11%)在放置关节囊间隔物后平均2.4±1.4年行翻修手术,症状性关节囊缺损是最常见发现。
  • 4例患者(7%)转为全髋关节置换。
  • 未再手术的髋(n=46)中,除SF-12心理成分总结外,结局评分显著改善;mHHS、HOS-ADL、HOS-SSS达到最小临床重要差异的比率分别为70%、70%、65%。

临床怎么用

  • 作者认为,当盂唇体积足够但粘连仍是顾虑时,翻修髋关节镜手术中应考虑使用关节囊间隔物。
  • 关节囊间隔物作为系统方法的一部分,包括粘连松解和术后早期持续物理治疗(含环转运动)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The presence of adhesions is a common source of pain and dysfunction after hip arthroscopic surgery and an indication for revision surgery. The placement of a capsular spacer in the capsulolabral recess after lysis of adhesions has been developed to treat and prevent the recurrence of adhesions. PURPOSE: To evaluate patient-reported outcomes (PROs) and survivorship at a minimum of 2 years after revision hip arthroscopic surgery with capsular spacer placement for capsular adhesions. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Between January 2013 and June 2018, a total of 95 patients (99 hips) aged ≥18 years underwent revision hip arthroscopic surgery for the treatment of capsular adhesions with the placement of a capsular spacer. Overall, 53 patients (56 hips) met the inclusion criteria and had a minimum 2-year follow-up, forming the cohort of this study. Exclusion criteria included confounding metabolic bone diseases (eg, Legg-Calve-Perthes disease, Marfan syndrome), labral deficiency, or advanced osteoarthritis (Tönnis grade 2 or 3). Preoperative and postoperative outcome scores (modified Harris Hip Score [mHHS], Hip Outcome Score-Activities of Daily Living [HOS-ADL], Hip Outcome Score-Sport-Specific Subscale [HOS-SSS], 12-Item Short Form Health Survey [SF-12], and Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC]) were collected and compared in addition to the revision rate, conversion to total hip arthroplasty, and patient satisfaction. RESULTS: The mean age of the cohort was 32 ± 11 years, with 32 female hips (57%) and a median number of previous hip arthroscopic procedures of 1 (range, 1-5). The arthroplasty- and revision-free survivorship rate at 2 years was 91%. Overall, 5 patients (6 hips; 11%) underwent revision surgery at a mean of 2.4 ± 1.4 years after capsular spacer placement, with symptomatic capsular defects being the most common finding. There were 4 patients (7%) who converted to total hip arthroplasty. For hips not requiring subsequent surgery (n = 46), there was a significant improvement in outcome scores except for the SF-12 Mental Component Summary, with rates of achieving the minimal clinically important difference of 70%, 70%, and 65% for the mHHS, HOS-ADL, and HOS-SSS, respectively. CONCLUSION: Capsular spacers, as part of a systematic approach including lysis of adhesions with early and consistent postoperative physical therapy including circumduction exercises, resulted in improved PROs as well as high arthroplasty- and revision-free survivorship (91%) at a minimum 2-year follow-up. Capsular spacers should be considered in revision hip arthroscopic procedures when an adequate labral volume remains but adhesions continue to be a concern.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Ruzbarsky JJ, Comfort SM, Martin MD, et al. Outcomes for Treatment of Capsulolabral Adhesions With a Capsular Spacer During Revision Hip Arthroscopy. Am J Sports Med. 2023. PMID: 36661250. doi:10.1177/03635465221145704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。